PNC-28 (20mg)
- PNC-28 (20mg) is a synthetic peptide derived from a mitochondrial targeting sequence of p53, designed to investigate selective apoptotic mechanisms in malignant cell models. This peptide functions by interacting with mitochondrial membranes in transformed cell populations, making it a promising research tool for studies focused on cancer biology and targeted peptide therapeutics.
- PNC-28 plays an important role in research examining apoptotic signaling pathways, p53-mediated stress responses, and differential cytotoxicity in neoplastic versus non-neoplastic cells. It has shown potential in modulating oncogenic processes in vitro, contributing to investigations of tumor suppression and cellular homeostasis.
- In addition to its observed cytotoxic properties in malignant models, PNC-28 may support further research into tumor immunogenicity and immune system interactions with transformed cells. PNC-28 (20mg) offers a valuable compound for exploring experimental approaches related to oncology, apoptosis regulation, and cancer peptide research.
$52.50
Original: $175.00
-70%PNC-28 (20mg)—
$175.00
$52.50Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
- PNC-28 (20mg) is a synthetic peptide derived from a mitochondrial targeting sequence of p53, designed to investigate selective apoptotic mechanisms in malignant cell models. This peptide functions by interacting with mitochondrial membranes in transformed cell populations, making it a promising research tool for studies focused on cancer biology and targeted peptide therapeutics.
- PNC-28 plays an important role in research examining apoptotic signaling pathways, p53-mediated stress responses, and differential cytotoxicity in neoplastic versus non-neoplastic cells. It has shown potential in modulating oncogenic processes in vitro, contributing to investigations of tumor suppression and cellular homeostasis.
- In addition to its observed cytotoxic properties in malignant models, PNC-28 may support further research into tumor immunogenicity and immune system interactions with transformed cells. PNC-28 (20mg) offers a valuable compound for exploring experimental approaches related to oncology, apoptosis regulation, and cancer peptide research.
